Home › NDC Lookup › Ingredients › Acetaminophen › 00904-1987-60
💊image loading
(from DailyMed)

MAPAP Extra Strength Acetaminophen 500 mg Capsule, 100-count — NDC 0904-1987-60 (Billing 00904-1987-60)

by Major Pharmaceuticals · 100 CAPSULE in 1 BOTTLE

This is a package of 100 capsules of MAPAP Extra Strength Acetaminophen 500 mg Capsule from Major Pharmaceuticals, marketed since Dec 1997 and currently FDA-listed; retail pharmacies pay about $0.0348 per capsule (NADAC). It is this product's only package size.

NDC 00904-1987-60
🏷️ FDA NDC (as labeled) 0904-1987-60 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0904-1987-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0904 labeler · 1987 product · 60 package
Package marketed since
Dec 22, 1997
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 0904198760 9
Medicaid fills, this package
51,166 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Acetaminophen (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 21, 2025 — Defective Container (Kenvue Brands LLC) · FDA recall D-0121-2026
Class II · Aug 20, 2025 — Discoloration (Baxter Healthcare Corporation) · FDA recall D-0596-2025
Class II · May 22, 2025 — cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets). (Aurobindo Pharma USA Inc) · FDA recall D-0471-2025
Class I · Jul 8, 2024 — Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) (Hikma Pharmaceuticals USA Inc.) · FDA recall D-0635-2024
Class II · May 20, 2024 — Discoloration: Brownish tablets (Contract Pharmacal Corporation) · FDA recall D-0566-2024
Class II · Nov 13, 2023 — Failed Impurities/Degradation Specifications (KINDER FARMS LLC) · FDA recall D-0143-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0904-1987-60
Product NDC 0904-1987
11-digit billing NDC 00904198760
NCPDP billing unit EA — each (per item)
RxCUI 198439, 209890
UNII 362O9ITL9D
Application # M013
SPL Set ID 34a95450-3f04-4de4-9113-73e7bd5724a0
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1997-12-22
Route ORAL
Dosage form CAPSULE
Substance ACETAMINOPHEN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 64200010000115
GPI class Mapap
GCN Seq No 004473
GCN 16892
HICL code 001866
Ingredient (HICL) Acetaminophen
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H3
Therapeutic class — intermediate (HIC2) Analgesics
HIC3 code H3E
Therapeutic class — specific (HIC3) Analgesic/Antipyretics,Non-Salicylate
AHFS code 28:08.16.00
AHFS class Non-Opioid Analgesics
FDB label name MAPAP 500 MG CAPSULE
FDB brand name Mapap
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 004473
  • GCN: 16892
  • GPI-14 (Medi-Span): 64200010000115
  • HICL (First Databank): 001866
  • AHFS class code: 28:08.16.00
  • RxCUI (RxNorm): 198439
Why two NDCs? The FDA registers this code as 0904-1987-60 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-1987-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Anilides class.

Drug family (ATC) Anilides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name MAPAP 500 MG CAPSULE Ingredient Acetaminophen
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves minor aches and pains, like headache, backache, toothache, muscle aches, cold aches, minor arthritis pain and menstrual cramps. It also reduces fever.
  • Follow your product label or prescriber exactly and never exceed the maximum daily amount. Remember that the limit counts every product with acetaminophen. Too much can seriously d...
  • Check the label first. Many combination products also contain acetaminophen, and you shouldn't use two together. If you aren't sure, ask me or your pharmacist.
  • Having 3 or more alcoholic drinks every day while using it raises the risk of liver damage. If you take warfarin, talk with your doctor or pharmacist first, since regular high dail...
📖 Read our full Acetaminophen guide →
1
Nutrient depletion considerations

Acetaminophen may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Acetaminophen nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.035 $3.48 / 100 capsules
Medicaid paysCMS SDUD · 12 mo $0.0791 $7.91 / 100 capsules
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Aug 2022 Feb 2026 Sep 2026 $0.052 $0.032
▲ Up 8% over the last 20 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00904-1987-60 You're viewing this Main listing 100 CAPSULE in 1 BOTTLE 1997-12-22 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
MAPAP Extra Strength 500 mgthis 00904-1987-60 Major 100 capsules $0.035 — Availability likely —
Pain Reliever 500 mg 00363-1178-50 Walgreens 50 capsules — — FDA listed —
Pain Reliever 500 mg 00363-6684-50 Walgreens 50 capsules — — FDA listed —
Acetaminophen 500 mg 35916-0183-02 Softgel 3000 capsules — — FDA listed —
Extra Strength Mini Softgels Pain Reliever 500 mg 41226-0101-50 THE 50 capsules — — FDA listed —
TYLENOL Extra Strength 500 mg 50580-0469-18 Kenvue 18 capsules — — FDA listed —
Extra Strength Mini Softgels Pain Reliever 500 mg 51316-0444-18 CVS 18 capsules — — FDA listed —
Pain Relief Extra Strength 500 mg 53345-0019-01 Humanwell 3000 capsules — — FDA listed —
Rapidol 500 mg 55758-0503-24 Pharmadel 24 capsules — — FDA listed —
Vicks PainQuil LIQUICAPS PAIN RELIEVER 500 mg 84126-0376-01 The 100 capsules — — FDA listed —
Extra Strength Pain Relief 500 mg 57896-0251-01 Geri-Care 100 capsules — — FDA listed —
Easyfast 500 mg 83174-0613-26 Easyfast 2 capsules — — Discontinued —
CVS Acetaminophen 500 mg 51316-0185-00 CVS 500 capsules — — FDA listed —
CVS Acetaminophen 500 mg 51316-0188-00 CVS 500 capsules — — FDA listed —
Extra Strength Acetaminophen 500 mg 87438-0001-01 Pinnacle 100 capsules — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1997
On the market since
Dec 1997
📍
2026
Currently FDA-listed
29 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Acetaminophen inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H3R47K3TBD
    FD&C Blue No. 1 is a synthetic blue dye approved for use in foods and medicines. It serves as a colorant to give the medication its distinctive appearance and help with product identification.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII 2G86QN327L
    Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
  • UNII U725QWY32X
    Povidone K30 is a synthetic polymer made from petroleum. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in the stomach so the medicine can be absorbed.
  • UNII 5856J3G2A2
    A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesFD&C blue #1, FD&C red #40, gelatin, polyvinylpyrrolidone, pregelatinized starch, sodium starch glycolate, stearic acid and titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM013 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedDec 1997
Product typeHuman Otc Drug
Portfolio630 products on file

More NDCs from Major Pharmaceuticals labeler code 00904

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🆘 Overdosage 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 27 words ▾

Uses Temporarily relieves fever and minor aches and pains due to: headache muscular aches the common cold toothache backache minor pain of arthritis premenstrual and menstrual cramps

⏱️ Dosage and Administration 63 words ▾

Directions do not take more than directed (see overdose warning) adults and children 12 years of age and over: take 2 capsules every 6 hours while symptoms last do not take more than 6 capsules in 24 hours, unless directed by a doctor do not take for more than 10 days unless directed by a doctor children under 12 years: ask a doctor

⚠️ Warnings ~1 min read ▾

Warnings Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take more than 6 capsules in 24 hours, which is the maximum daily amount with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include: skin reddening blisters rash If a skin reaction occurs, stop use and seek medical help right away.

Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you are allergic to acetaminophen or any of the inactive ingredients in this product Ask a doctor before use if you have liver disease Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin Stop use and ask a doctor if pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days new symptoms occur redness or swelling is present These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. Overdose warning: In the case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

🆘 Overdosage 41 words ▾

Overdose warning: In the case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

🧪 Active Ingredient 10 words ▾

Drug Facts Active ingredient (in each capsule) Acetaminophen 500 mg

🧪 Inactive Ingredients 20 words ▾

Inactive ingredients FD&C blue #1, FD&C red #40, gelatin, polyvinylpyrrolidone, pregelatinized starch, sodium starch glycolate, stearic acid and titanium dioxide

🎯 Purpose 4 words ▾

Purpose Pain reliever/fever reducer

📄 Do Not Use 42 words ▾

Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you are allergic to acetaminophen or any of the inactive ingredients in this product

📄 Ask a Doctor Before Use If 10 words ▾

Ask a doctor before use if you have liver disease

📄 Ask a Doctor or Pharmacist Before Use If 16 words ▾

Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin

📄 Stop Use and Ask a Doctor If 41 words ▾

Stop use and ask a doctor if pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days new symptoms occur redness or swelling is present These could be signs of a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Other Information 14 words ▾

Other information store in a dry place at 15° – 30°C (59° – 86°F).

📄 Questions or Comments 8 words ▾

Questions or comments? Call 1-800-231-4670 Monday-Friday 9AM-5PM ET

📄 Package Label / Principal Display Panel 21 words ▾

Major NDC 0904-1987-60 extra strength Mapap® acetaminophen 500 mg each pain reliever / fever reducer aspirin free 100 capsules Major label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
51.2K
Units reimbursed last 4 qtrs
3.1M
Gross reimbursed last 4 qtrs
$242.1K
Avg / prescription
$4.73
Avg / unit
$0.0791
Latest quarter Q4 2025
13.5KRx
Medicaid pays / ea
$0.0791
gross reimbursed
vs
NADAC / ea
$0.0348
acquisition cost
=
Spread
+$0.0443
+127% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
24% FFS 76% MCO
Fee-for-service · 12,302 Rx Managed care · 38,864 Rx
State Medicaid map
Alaska: no data reported AK Maine: 24,899 units · 1,785 per 100k residents ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 114,868 units · 2,002 per 100k residents MN Wisconsin: 41,585 units · 704 per 100k residents WI Michigan: 117,915 units · 1,175 per 100k residents MI New York: 627,423 units · 3,206 per 100k residents NY Vermont: 33,804 units · 5,225 per 100k residents VT New Hampshire: 4,989 units · 356 per 100k residents NH Oregon: 97,602 units · 2,306 per 100k residents OR Nevada: 18,474 units · 578 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 24,252 units · 193 per 100k residents IL Indiana: 97,295 units · 1,418 per 100k residents IN Ohio: 80,734 units · 685 per 100k residents OH Pennsylvania: 39,090 units · 302 per 100k residents PA New Jersey: 13,531 units · 146 per 100k residents NJ Massachusetts: 160,344 units · 2,290 per 100k residents MA California: 17,068 units · 43.8 per 100k residents CA Utah: no data reported UT Colorado: 1,382 units · 23.5 per 100k residents CO Nebraska: 7,522 units · 380 per 100k residents NE Missouri: no data reported MO Kentucky: 33,241 units · 734 per 100k residents KY West Virginia: 1,867 units · 105 per 100k residents WV Virginia: 21,350 units · 245 per 100k residents VA Maryland: 22,859 units · 370 per 100k residents MD Connecticut: no data reported CT Rhode Island: 8,178 units · 747 per 100k residents RI Arizona: 47,154 units · 635 per 100k residents AZ New Mexico: no data reported NM Kansas: 1,476 units · 50.2 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 2,225 units · 41.4 per 100k residents SC Delaware: 5,150 units · 500 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 864 units · 7.8 per 100k residents GA D.C.: 48,772 units · 7,183 per 100k residents DC Hawaii: 28,894 units · 2,014 per 100k residents HI Texas: 1,314,558 units · 4,310 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
7.87,183
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 D.C. 7,183 /100k
2 Vermont 5,225 /100k
3 Texas 4,310 /100k
4 New York 3,206 /100k
5 Oregon 2,306 /100k
6 Massachusetts 2,290 /100k
7 Hawaii 2,014 /100k
8 Minnesota 2,002 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Acetaminophen (matched by generic name) — the program that covers self-administered drugs. 5 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Acetaminophen. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$34K
Claims incl. refills
277
Beneficiaries
145
Spend / beneficiary
$234.25
Spend / claim
$122.62
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for MAPAP Extra Strength (this brand).

Top reported reactions

Fatigue20,937
Pain18,492
Nausea18,186
Headache17,144
Toxicity To Various Agents15,844
Dyspnoea15,022
Pyrexia14,591

Age at onset

Neonate562
Infant376
Child2,615
Adolescent2,133
Adult26,673
Elderly17,792

Reporter sex

254,005 reports
Male · 38%
Female · 62%
Unknown · 0%

Serious outcomes

Hospitalization114,449
Life-threatening21,908
Disabling12,033
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 28,620 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 00904-1103-09 · Major 00904-2015-59 · Major →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.